Quinolines and derivatives

6(5H)-Phenanthridinone 98.0+%, TCI America™

CAS: 1015-89-0 Molecular Formula: C13H9NO Molecular Weight (g/mol): 195.221 MDL Number: MFCD00004988 InChI Key: RZFVLEJOHSLEFR-UHFFFAOYSA-N Synonym: 6 5h-phenanthridinone,phenanthridin-6 5h-one,6-phenanthridinol,phenanthridone,6-5h-phenanthridinone,6-phenanthridone,6-phenanthridinone,6 5h-phenanthridone,phenanthridin-6-ol,phenantridone PubChem CID: 1853 ChEBI: CHEBI:75292 IUPAC Name: 5H-phenanthridin-6-one SMILES: C1=CC=C2C(=C1)C3=CC=CC=C3NC2=O

Decoquinate 97.0+%, TCI America™

CAS: 18507-89-6 Molecular Formula: C24H35NO5 Molecular Weight (g/mol): 417.546 MDL Number: MFCD00673686 InChI Key: JHAYEQICABJSTP-UHFFFAOYSA-N Synonym: 6-Decyloxy-7-ethoxy-4-hydroxyquinoline-3-carboxylic Acid Ethyl Ester, Ethyl 6-Decyloxy-7-ethoxy-4-hydroxyquinoline-3-carboxylate PubChem CID: 29112 IUPAC Name: ethyl 6-decoxy-7-ethoxy-4-oxo-1H-quinoline-3-carboxylate SMILES: CCCCCCCCCCOC1=C(C=C2C(=C1)C(=O)C(=CN2)C(=O)OCC)OCC

Levofloxacin Q-Acid 98.0+%, TCI America™

CAS: 100986-89-8 Molecular Formula: C13H9F2NO4 Molecular Weight (g/mol): 281.215 MDL Number: MFCD04039905 InChI Key: NVKWWNNJFKZNJO-YFKPBYRVSA-N Synonym: levofloxacin q-acid,levofloxacin carboxylic acid,s-9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2h-1,4 oxazino 2,3,4-ij quinoline-6-carboxylic acid,unii-08gt8fy84e,levofloxacin related compound b,levofloxacin acid,3s-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7h-pyrido 1,2,3-de-1,4-benzoxazine-6-carboxylic acid,levofloxacin q-acid,-,s-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido 1,2,3-de-1,4-benzoxazine-6-carboxylic acid,levofloxacin related compound b usp PubChem CID: 688333 SMILES: CC1COC2=C3N1C=C(C(=O)C3=CC(=C2F)F)C(=O)O

Medchemexpress LLC Ipatasertib | 1001264-89-6 | 458.00 | 200 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

Ipatasertib (GDC-0068) is an orally active, highly selective, and ATP-competitive pan-Akt inhibitor. It activates FoxO3a and NF-κB through Akt inhibition, leading to p53-independent activation of PUMA, and induces apoptosis in cancer cells and inhibits tumor growth in xenograft mouse models.

• Orally active and highly selective pan-Akt inhibitor
• ATP-competitive inhibition of Akt1, Akt2, and Akt3
• Synchronously activates FoxO3a and NF-κB
• Leads to p53-independent activation of PUMA
• Induces apoptosis in cancer cells
• Inhibits tumor growth in xenograft mouse models

Medchemexpress LLC 6-[2-[4-[(4-fluorophenyl)-phenylmethylidene]piperidin-1-yl]ethyl]-7-methyl-thiazolo[3,2-a]pyrimidin- | 93076-89-2 | MFCD00055114 | 99.8% | 459.58 | C27H26FN3OS | 50 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

R 59-022 is a small-molecule diacylglycerol kinase (DGK) inhibitor for biochemical and cellular research. It modulates protein kinase C activity, acts as a 5-HT receptor antagonist, and potentiates thrombin-induced diacylglycerol production in platelets. It is supplied as a solid for in vitro studies.

• Diacylglycerol kinase inhibitor with reported IC50 ≈2.8 μM.
• Modulates protein kinase C and 5-HT receptor activity.
• High purity (99.8% by HPLC).
• Molecular weight 459.58 g/mol.
• Supplied as small-scale solid suitable for in vitro research.

Medchemexpress LLC 6-[2-[4-[(4-fluorophenyl)phenylmethylene]-1-piperidinyl]ethyl]-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one | 93076-89-2 | MFCD00055114 | 99.8% | 459.58 g·mol⁻¹ | C27H26FN3OS | 100 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

R 59-022 is a small-molecule diacylglycerol kinase (DGK) inhibitor used in biochemical and cell-based studies to probe DAG/PKC signaling and lipid metabolism. It also functions as a 5-HT receptor antagonist and activates protein kinase C, potentiating thrombin-induced diacylglycerol production in platelets.

• Inhibits diacylglycerol kinase activity (IC50 ~2.8 μM).
• Acts as a 5-HT receptor antagonist and activates protein kinase C.
• Modulates diacylglycerol and phosphatidic acid metabolism in cells.
• High purity suitable for biochemical assays and cell studies.
• Offered in solid and solution formats for flexible experimental use.

Medchemexpress LLC 6-(2-(4-((4-fluorophenyl)phenylmethylidene)piperidin-1-yl)ethyl)-7-methyl-thiazolo[3,2-a]pyrimidin-5-one | 93076-89-2 | MFCD00055114 | ≥98.0% | 459.58 g/mol | C27H26FN3OS | 25 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

R 59-022 is a small-molecule research reagent that inhibits diacylglycerol kinase (DGK) and functions as a 5-HT receptor antagonist. It is used to modulate protein kinase C (PKC) activation and diacylglycerol-dependent signaling in biochemical and cell-based studies. Chemical identifiers include CAS 93076-89-2, formula C27H26FN3OS, and molecular weight ≈459.58 g/mol.

• Potent DGK inhibitor (reported IC50 ≈ 2.8 μM).
• Modulates PKC activation and diacylglycerol signaling.
• Used in platelet aggregation and cellular signaling studies.
• High reported purity (≥98%).
• Provided in small research quantities suitable for assay development.